|
WIZ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.541700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.457800E-03 |
| Normal-vs-Stage2 |
5.010000E-02 |
| Normal-vs-Stage3 |
4.203200E-01 |
| Normal-vs-Stage4 |
3.370400E-01 |
| Stage1-vs-Stage2 |
9.192200E-01 |
| Stage1-vs-Stage3 |
1.830420E-02 |
| Stage1-vs-Stage4 |
8.925600E-01 |
| Stage2-vs-Stage3 |
4.060400E-02 |
| Stage2-vs-Stage4 |
9.555800E-01 |
| Stage3-vs-Stage4 |
1.964010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.266300E-02 |
| Normal-vs-AfricanAmerican |
2.055000E-01 |
| Normal-vs-Asian |
7.036000E-01 |
| Caucasian-vs-AfricanAmerican |
7.850200E-01 |
| Caucasian-vs-Asian |
9.578600E-01 |
| AfricanAmerican-vs-Asian |
9.666000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.085980E-02 |
| Normal-vs-Female |
5.389200E-01 |
| Male-vs-Female |
3.080700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.875700E-02 |
| Normal-vs-Extreme_Weight |
5.720700E-03 |
| Normal-vs-Obese |
9.462400E-01 |
| Normal-vs-Extreme_Obese |
1.662020E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.905400E-01 |
| Normal_Weight-vs-Obese |
7.894100E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.132400E-01 |
| Extreme_Weight-vs-Obese |
1.392230E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.231600E-01 |
| Obese-vs-Extreme_Obese |
3.618800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.168200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.812000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.615900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.335770E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.744300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.979060E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.599600E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.489600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.709800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.241400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.759350E-01 |
| Normal-VS-Type2 PRCC |
1.776450E-04 |
| Normal-VS-KIRP CIMP |
5.587700E-02 |
| Normal-VS-Unclassified PRCC |
7.388200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.803200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.428500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.451800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.835300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.316410E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.340270E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.287860E-02 |
| Normal-vs-N1 |
2.983000E-01 |
| Normal-vs-N2 |
7.092000E-01 |
| N0-vs-N1 |
6.338400E-03 |
| N0-vs-N2 |
1.622000E-01 |
| N1-vs-N2 |
9.619000E-01 |
|
|
